On the recordJuly 26, 2017
I look forward to hearing the witnesses' views on these issues and whether our existing antitrust laws are equipped to address these antitrust concerns in the FDA approval process.
Source
congress.govEditor's note · Context
Marino emphasizes the need for discussion on antitrust laws related to FDA processes.
Share
More from Tom Marino
Sep 7, 2018
I would like to make some clarifications. First of all, I am tired of hearing from the other side that bills are rushed through, bills are pushed through, there is no thought put into this, which is nothing more than a red herring. {time}…
Sep 7, 2018
I want to thank Congresswoman Handel for bringing this forth, this very important piece of legislation that has been reviewed by the United States Supreme Court. The Supreme Court in Sessions v. Dimaya ruled that 18 U.S.C. Section 16 was…
Jun 15, 2018
I claim the time in opposition to the amendment, although I am not opposed to the amendment. The Acting CHAIR. Without objection, the gentleman from Pennsylvania is recognized for 5 minutes. There was no objection.
Jun 15, 2018
Section 9 of the bill would provide guidance in sentencing during the current problematic time for courts, prosecutors, and defendants. Courts are having difficulties similar to those of law enforcement because of the constantly evolving…
Other voices in this conversation
